As part of the 100th anniversary of the discovery of insulin, the Alberta Diabetes Foundation (ADF), Diabetes Research Institute Foundation Canada (DRIFCan), and the University of Alberta Faculty of Medicine & Dentistry (FoMD) are joining forces to offer an unprecedented opportunity for funding projects in T1D, T2D or gestational diabetes that will translate innovative research into novel health care applications. This competition is to support big, bold, collaborative research projects aimed at curing diabetes.
This is a call to our researchers for LOIs, and is the first step in funding this initiative. Researchers are asked to develop plans built around their world-leading expertise that demonstrate a means to accomplish major goals given the right resources and team.
The deadline for receipt of the LOI is July 1, 2020. LOI submissions will then be used by the Alberta Diabetes Institute and the funding partners to develop a targeted fundraising strategy that can be presented to the philanthropic community. Once a significant amount of the funds have been secured for specific projects of interest to donors, the teams will then be asked for a full proposal for comprehensive scientific peer review. Throughout this campaign donors will be able to make designated gifts to support specific projects and research taking place.
While any exciting project idea is welcomed, we encourage applicants to develop translational research ideas that fall under the themes as detailed in Part B of the file below. Team collaboration is imperative for this type of endeavor and a strong team approach will greatly strengthen the LOI.
There is no set limit on budget, although $5-10M over 5-10 years may be a practical limit. All direct costs associated with the project are eligible. The Principal Investigator will be part of a stakeholder group that will oversee progress, assist with translational planning and help procure additional funding.
The Principal Applicant may be any full-time faculty member at an accredited university in Alberta who has demonstrated exceptional leadership in their field of research and a track record of
accomplishment in diabetes research and development. Co-applicants can be chosen from within or outside the Province and the team should be chosen with high impact and translational research in mind. Researchers may be a principal applicant on one LOI and a co-applicant on up to two additional applications. If they are not a principal applicant they may be a co-applicant on up to three applications.
For more information, please see the attached file.